Literature DB >> 25579828

Non-tuberculous mycobacterial infections of the hand.

N Balagué1, I Uçkay2, P Vostrel3, H Hinrikson4, I Van Aaken3, J-Y Beaulieu3.   

Abstract

UNLABELLED: Non-tuberculous mycobacterial infections of the hand are difficult to treat and require a long time before remission. But how long should we wait to see an improvement? To answer this question, the published scientific literature was reviewed in English, French and German. Tuberculosis, arthritis and osteomyelitis cases were excluded. A total of 241 non-tuberculous mycobacterial hand infections in 38 scientific publications were retrieved. Most were case reports or series. The median age of the patients was 58years and one third was female. Patients were immunocompromised in 17 episodes. The most common species were Mycobacterium marinum in 198 episodes (82%), followed by M. chelonae in 13 cases (5%). There were no cases of mixed infection. Most infections were aquatic in origin and community-acquired, and were treated with a combination of surgical debridement and long-duration systemic combination antibiotic therapy (14 different regimens; no local antibiotics) for a median duration of 6months. The median number of surgical procedures was 2.5 (range 1-5). Clinical success was not immediate: a median period of 3months (range 2-6) was necessary before the first signs of improvement were observed. The majority (173 cases; 76%) remained entirely cured after a median follow-up time of 1.7years (range, 1-6). Only two microbiological recurrences occurred (1%). However, 49 patients (21%) had long-term sequelae such as pain, stiffness and swelling. The approach of long-duration antibiotic treatment in combination with repeated surgery for mycobacterial soft tissue infections of the hand leads to few recurrences. However, clinical success is not immediate and may take up to 3months. TYPE OF STUDY: Therapeutic study: systematic review of level III studies. LEVEL OF EVIDENCE: III.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Mycobacteria; Mycobactéries; Tenosynovitis; Traitement; Treatment; Ténosynovite

Mesh:

Year:  2014        PMID: 25579828     DOI: 10.1016/j.main.2014.12.004

Source DB:  PubMed          Journal:  Chir Main        ISSN: 1297-3203


  6 in total

Review 1.  Mycobacterial Infections of the Hand.

Authors:  Vivek K Bilolikar; Asif M Ilyas
Journal:  Hand (N Y)       Date:  2020-09-17

2.  Flexor Tenosynovitis of the Hand Caused by Mycobacterium tuberculosis.

Authors:  Samuel Cohen-Tanugi; Margart L Wright; R Kumar Kadiyala
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2018-04-23

3.  Two weeks versus four weeks of antibiotic therapy after surgical drainage for native joint bacterial arthritis: a prospective, randomised, non-inferiority trial.

Authors:  Ergys Gjika; Jean-Yves Beaulieu; Konstantinos Vakalopoulos; Morgan Gauthier; Cindy Bouvet; Amanda Gonzalez; Vanessa Morello; Christina Steiger; Stefanie Hirsiger; Benjamin Alan Lipsky; Ilker Uçkay
Journal:  Ann Rheum Dis       Date:  2019-04-16       Impact factor: 19.103

4.  Short postsurgical antibiotic therapy for spinal infections: protocol of prospective, randomized, unblinded, noninferiority trials (SASI trials).

Authors:  Michael Betz; Ilker Uçkay; Regula Schüpbach; Tanja Gröber; Sander M Botter; Jan Burkhard; Dominique Holy; Yvonne Achermann; Mazda Farshad
Journal:  Trials       Date:  2020-02-06       Impact factor: 2.279

5.  Idiopathic tenosynovitis with rice bodies.

Authors:  Mihaela Perţea; Bogdan Veliceasa; Natalia Velenciuc; Cristina Terinte; Mihaela Mitrea; Petru Ciobanu; Ovidiu Alexa; Sorinel Luncă
Journal:  Rom J Morphol Embryol       Date:  2020 Apr-Jun       Impact factor: 1.033

6.  Non-tuberculosis Mycobacterium Tenosynovitis with Rice Bodies in a Patient with Systemic Lupus Erythematosus.

Authors:  Yuichiro Fujieda; Keita Ninagawa; Yuichiro Matsui; Michihiro Kono; Tamotsu Kamishima; Norimasa Iwasaki; Tatsuya Atsumi
Journal:  Intern Med       Date:  2020-06-15       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.